Bill B.

Wellsboro, PA

Bill’s Testimonial for Lung Disease Treatment

Age: 82  |  Location: Wellsboro, PA  |  Condition: COPD

When Bill B.’s COPD was causing increased shortness of breath and made daily activities challenging, he knew it was time to investigate other options. Bill’s pulmonary function test showed that he wasn’t receiving enough oxygen, so his physician prescribed inhalers and supplemental oxygen. Before treatment at the Lung Institute, Bill had trouble walking down his driveway to get the mail, and if he had to go downtown, he used a scooter. Afraid he might have an attack, Bill stopped doing his favorite activities. After treatment, Bill feels better and says that, while he understands COPD is a progressive disease, his COPD seems to have been halted in its tracks. Now, Bill looks forward to taking his boat out to go bass fishing, staying involved in his theater group and helping with the library’s book sale. As Bill says, “For me, it’s astounding.”

If you or a loved one has COPD or another chronic lung disease and would like to see results like Bill’s, please feel free to contact us today at 888-745-6697 to learn more about cellular therapy options.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.